The 5th European Congress on Controversies in Leukemia, taking place 26–27 October in Munich, Germany. This congress has been carefully designed to bring together leading clinicians, researchers, and innovators from across Europe and beyond, creating a dedicated forum for open, evidence-driven dialogue on the most pressing and debated questions in leukemia management today. The congress will focus on: Place of ASCT in the era of molecular medicine in AML MRD monitoring in AML Place of chemotherapy in the era of immunotherapy in ALL